Table 5.
Factors associated with missed opportunities for HPV vaccination, overall and by visit type.
| % Qualifying visits that were missed opportunities for HPV vaccine administration | ||||
|---|---|---|---|---|
| Preventive | Problem-focused | Immunization-only | ||
| By visit type* | 62% | 89% | 18% | |
| Clinic/patient characteristic (total # visits)§ | All visit types combined | By visit type | ||
| Preventive | Problem-focused | Immunization-only | ||
| Specialty* | ||||
| Pediatrics (n = 15,915) | 71% | 60% | 89% | 17% |
| Family medicine (n = 5,040) | 73% | 66% | 87% | 24% |
| Gynecology (n = 879) | 81% | 84% | 93% | 2% |
| Race* | ||||
| White (n = 16,758) | 72% | 65% | 89% | 17% |
| African American (n = 2,610) | 68% | 50% | 86% | 15% |
| Other/not specified (n = 2,466) | 73% | 65% | 89% | 28% |
| Age at time of visita | ||||
| 11–12 (n = 5,560) | 77% | 66% | 93% | 28% |
| 13–15 (n = 5,809) | 70% | 61% | 88% | 16% |
| 16+ (n = 5,615) | 70% | 60% | 86% | 14% |
| Insurance at time of visit‡,† | ||||
| Private (n = 17,232) | 73% | 66% | 90% | 19% |
| Public (n = 3,034) | 68% | 48% | 84% | 14% |
| Concurrently received other adolescent vaccines at visit* | NS | |||
| Yes (n = 10,387) | 63% | 57% | 83% | 18% |
| No (n = 11,447) | 80% | 70% | 93% | 18% |
NS: not significant.
*
p < 0.0001.
†
p < 0.05.
§
Includes missed opportunity visits plus visits that were not missed opportunities.
a
9–10 year olds were eliminated from the analysis since routine HPV vaccination is recommended beginning at age 11 years.
‡
Patients with no insurance were eliminated from the analysis due to small cell sizes.